About to KABOOM on both US and Canada sides+10.7% @0.30$US on 162K volume
+8.0% @0.405$CAN on 180K volume
BID @0.405$ (167 lots) ASK @0.41$ (17).
It's a question of time before we hit even higher.
5y high is 0.56$CAN
3y high is 0.48$CAN
Market valuation (instead of share price) is the best indicator to better assess where we should fairly trade.
Even @0.56$CAN, we would only be valued at a mere 120M$CAN (88M$US). Knowing that a real contender to a future SOC can easily be worth 500M$US and that a about-to-be-approved usually trades @1B$US+, we still have lots of room to grow.
Especially that the NMIBC market is a major one and that a big pharma wanting to jv with us would advance our molecule to early-stage NMIBC market. That would be the end of the unreliable BCG. BCG market is currently worth 17B$US.
So lets first stabilize to 250M-400M$US before the FDA decision, if logic prevails. That would bring the share price between 2.85x-4.50x the 0.56$CAN valuation (so 1.60$-2.52$CAN ... 1.17$-1.85$US).
So we still have room to grow. Lots of.
Let the wind blow into the sails.
CAN to US$ = 1.36